Technical analysis of Bausch Health Companies Inc. (BHC): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology.
Price Performance
| 1 month | +55.50% |
| 3 months | +29.32% |
| Year-to-date | +28.20% |
| 1 year | +26.92% |
| 3 years | +25.85% |
| 5 years | -68.77% |
| 10 years | -57.81% |
52-Week Range
| 52-week High | $9.04 |
| 52-week Low | $4.33 |
| Avg Volume (90d) | 3.5M |
Technical Indicators
| SMA 50 | $6.21 |
| SMA 200 | $5.70 |
| Beta | 0.40 |
| 30-day Volatility (annualised) | 79.3% |
| Price vs SMA 50 | +43.5% |
| Price vs SMA 200 | +56.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $6.95 | |
| 2026-01 | $5.74 | -17.4% |
| 2026-02 | $5.93 | +3.3% |
| 2026-03 | $5.40 | -8.9% |
| 2026-04 | $5.72 | +5.9% |
| 2026-05 | $5.36 | -6.3% |
| 2026-06 | $4.93 | -8.0% |
| 2026-07 | $6.89 | +39.8% |
| 2026-08 | $6.37 | -7.5% |
| 2026-09 | $5.83 | -8.5% |
| 2026-10 | $8.91 | +52.8% |
| 2026-10 | $8.91 | +0.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-17 | $1.32 | $2.81B |
| 2026-10-28 | $1.25 | $2.72B |
| 2026-07-29 | $0.96 | $2.59B |
| 2026-04-29 | $0.81 | $2.37B |
| 2026-02-18 | $1.21 | $2.73B |
| 2025-10-29 | $1.07 | $2.71B |
| 2025-07-30 | $0.97 | $2.58B |
Price
| Price | $8.20 (closing price, October 30, 2026) |
| Market Cap | $3.1B |
| Exchange | NYSE |
| Country | CA |
Valuation Ratios
| Price / Book | -1.79 |
| EV / EBITDA | 0.46 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -0.65 |
| Current Ratio | 1.56 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 0.30 |